Since 2005, the U.S. Preventive Services Task Force has recommended screening for unaffected (i.e., no personal history of cancer) women with a strong family history of certain cancers to identify those who may be at increased risk for potentially harmful pathogenic variants in BRCA1/2 [23]. This evidence concerns the gene BRCA1 and cancer.